医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Wipro Recognized as a Leader in Everest Group PEAK Matrix™ Healthcare Payer Digital Services Assessment 2020

2020年03月05日 PM10:15
このエントリーをはてなブックマークに追加


 

EAST BRUNSWICK, N.J. & BANGALORE, India

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it has been positioned as a ‘Leader’ in Everest Group PEAK Matrix™ Healthcare Payer Digital Services Assessment with Service Provider Landscape 2020.

The report evaluated the digital services capabilities of 23 IT service providers, in the healthcare payer sector globally and mapped them on the Everest Group PEAK Matrix™ based on several vision and capability, and market impact-related parameters. Wipro was positioned as a leader owing to its balanced portfolios, the ability to come up with innovative digital use cases, and continued investments in technology and services capability development.

According to the report, Wipro’s solutions are designed to manage various providers, payers and beneficiary (patients) data in compliance with government regulations. Wipro Healthcare has worked on unlocking new value streams in healthcare digital delivery leveraging its strong capabilities in digital technologies and consulting to deliver end-to-end engagement with clients.

“The healthcare industry is experiencing fundamental changes – including a shift from a volume- to a value-based care model, the entry of technology players, and the increasing importance of patient centricity. As a result, payers are adopting digital technologies to enhance their operating models and optimize costs, and they are looking for service providers to help navigate challenges such as siloed operations, disconnected information systems, and fragmented member information, to truly focus on breakthrough innovation and value-based care outcomes,” said Nitish Mittal, Vice President, Everest Group. “With its consultative approach, design-thinking-led solutions, focus on digital-led transformation and platform-play, Wipro is emerging as a partner of choice.”

Mohd Ehteshamul Haque, Senior Vice President and Global Head – Healthcare and Services Vertical, Wipro Limited said, “Members of health plans today expect better care and digital engagement at lower premiums. Our Payer strategy addresses the changing market by helping health plans create personalized member experiences at competitive costs. Our three-pronged approach of leading with tailored Digital Platforms, Digital Operations and Digital Transformation for the Payer Market is paying off. Our rating as a Leader underlines the success of our strategy for this unique segment.”

To know more about the report click here – https://www.wipro.com/healthcare/form/wipro-positioned-as-a-leader-in-the-healthcare-payer-digital-service-providers-peak-matrix-assessment-2020/

About Wipro Limited

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading global information technology, consulting and business process services company. We harness the power of cognitive computing, hyper-automation, robotics, cloud, analytics and emerging technologies to help our clients adapt to the digital world and make them successful. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, we have over 175,000 dedicated employees serving clients across six continents. Together, we discover ideas and connect the dots to build a better and a bold new future.

Forward-looking and Cautionary Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200305005458/en/

CONTACT

Wipro Media Contact:

Purnima Burman

Wipro Limited

purnima.burman@wipro.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Jichi Medical University and CureApp, Inc.: The First Phase 3 Clinical Trials of “Digital Therapeutics” for Hypertension Begin in Japan
  • EUSA Pharmaとイタリアのパパ・ジョヴァンニ23世病院がSISCO研究でシルツキシマブ治療を受けたCOVID-19患者の中間解析データを発表
  • EUSA Pharma和意大利Papa Giovanni XXIII医院提供Siltuximab治疗COVID-19患者的SISCO研究中期分析数据
  • Celltrion’s COVID-19 Antiviral Treatment Enters the Next Phase of Development
  • ‘Oracle Water’ Delivers Remarkable Ability of Effectively Sterilizing COVID-19